How to Master Office-Based Rhinitis and Sinusitis Surgery

Tuesday, October 1, 2024

9:30 AM – 10:30 AM EDT

Location: MBCC, 225

CME/MOC Credit: 1

Disclosure(s):

Satish Govindaraj, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Anthony G. Del Signore, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Michael Setzen, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Joseph A. Capo, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: The field of rhinology has expanded to offer patients therapeutic interventions in the office setting. The
treatment of rhinitis and sinusitis is an area of rapid growth with multiple treatment options and techniques.
Treatment of rhinitis, nasal obstruction and balloon sinuplasty in the office setting has been well established.
The expansion of this therapeutic offering to include sinus surgery is the natural evolution. As the outpatient
office functions as an operating room quality control, case selection, staff training and office scheduling become critical aspects to deliver proper care in a safe manner. In addition, optimization of ergonomics is
critical to ensure longevity of the office based surgeon. The goals of the presentation will be to deliver a
practical description of techniques and case selection that will allow the attendee to return to their practices
and offer their patients office based treatment for rhinitis and sinusitis. Case selection will demonstrate
patients with anatomy that would more suited for the office setting. Organization of the office operating
room including the proper training of staff, instrument set up, and cost containment will be discussed.
Additional goals will focus on pain control and anesthesia protocols for local anesthesia and optimization of
the patient experience in office procedures.

Learning Objectives:

Analyze cases with chronic rhinitis and sinusitis that are amenable and not amenable to office based sinus surgery. Participants will understand where office based rhinologic surgery would be an appropriate therapeutic option and how to perform the procedure safely.
Understand the necessary equipment, instrumentation, local anesthetics, and office set up to perform safe and effective office based sinus surgery, Participants will be given tables and images of instrumentation and set up that will facilitate participants implementing what they will learn.
Understand the utilization of instrumentation and disposables that allow cost effective delivery of office sinus and rhinitis surgery. Participants will understand the appropriate selection of instrumentation and disposables to deliver a cost effective sinus surgery in an office setting.

Moderator(s)

Satish Govindaraj, MD

Associate Professor of the Department of Otolaryngology and Neurosurgery
Mount Sinai School of Medicine
New York, NY, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Panelist(s)

Anthony G. Del Signore, MD

Assistant Professor in the Department of Otolaryngology and Director of Rhinology and Endoscopic Skull Base Surgery
Mount Sinai School of Medicine
NYC, NY, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
MS

Michael Setzen, MD

Clinical Professor of Otolaryngology
Weill Cornell Medical College
Great Neck, NY, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
JC

Joseph A. Capo, MD

Medical Director
Capo Nose and Sinus Center, Adjunct Assistant Professor, Department of Surgery at NYU Long Island School of Medicine
Sea Cliff, NY, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.